Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rab Razzak

Hospice & Palliative Care · Sutter Health

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Rebecca Andrews

Primary Care · UCHC

View

Dr. David Bates

General Internal Medicine · BWH

View

Dr. Reema Dbouk

Obesity Medicine · Emory University

View

Dr. Jennifer Paisley

Obesity Medicine · St. Elizabeth Medical Center

View

Dr. Molly Heublein

Primary Care · Clear Medical Clinic

View

Dr. Ryan Mire

Primary Care · Heritage Medical Associates

View

Dr. Alpesh Amin

Hospital Medicine · UCI

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    LY

    Dr. Linda Yu

    Internal Medicine · Hospice and Palliative Care
    Memorial Sloan Kettering Cancer Center
    linday

    Research

    Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

    2024

    Via Journal of Clinical Oncology

    Research

    Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma

    2023

    Via JAMA Network Open

    Research

    Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

    2022

    Via CA A Cancer Journal for Clinicians

    Research

    Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus–Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy

    2022

    Via JAMA Oncology

    Research

    Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

    2021

    Via JAMA Network Open

    Research

    Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers

    2020

    Via JAMA Oncology